ERBB2 and breast carcinoma: In human epidermal growth factor receptor 2 (HER2)+ breast cancer cells, knockdown of ESE1 inhibits cell proliferation and tumor sphere formation by inhibiting HER2‐dependent signaling, therefore displaying a pro‐tumorigenic role.17, 18, 19